Moreover, diltiazem also reduced myocardial ischemia, endothelia dysfunction and inflammatory responses, as indicated by changes in c-TnI, plasma vWF and ET-1 levels, as well as the myocardial protein expression levels of TNF-α and IL-6. The gene discussed is EDN1; the disease is myocardial ischemia.